Systematic review finds dairy trans fats not linked to higher cardiovascular risk — Evidence Review
Published in Nutrition Research, by researchers from University of Reading
Table of Contents
A large systematic review found that trans fats naturally present in dairy foods do not appear to increase the risk of heart disease, stroke, or diabetes, contrasting with the well-established harms of industrial trans fats. Most related research supports this distinction, though some earlier studies noted modest effects on cholesterol that did not translate into clear health risks. The findings, based on thousands of participants, suggest that naturally occurring dairy trans fats behave differently from their industrial counterparts, as also indicated by the University of Reading study.
- Several large meta-analyses and reviews consistently report that industrial trans fats are associated with increased cardiovascular risk, while dairy-derived (ruminant) trans fats are not linked to higher rates of heart disease or mortality in long-term population studies 5 11 14.
- Mechanistic and randomized controlled studies indicate that industrial trans fats promote inflammation and adverse lipid changes, whereas ruminant trans fats from dairy may have more neutral or even beneficial effects, particularly for certain blood markers 2 3 6 8 9.
- Some studies suggest that all trans fats can influence cholesterol ratios, yet the magnitude and clinical significance differ, with industrial sources posing greater risk compared to natural dairy fats 7 8 10.
Study Overview and Key Findings
Public concern about trans fats has led to widespread reformulation and regulation of food products, primarily targeting industrially produced trans fats due to their association with cardiovascular disease. However, naturally occurring trans fats remain present in dairy foods, and their health implications have been less clear. This systematic review addresses a crucial gap by distinguishing between trans fats from dairy and those from industrial sources, analyzing both short-term intervention trials and long-term cohort studies to assess their impact on major health outcomes.
| Property | Value |
|---|---|
| Study Year | 2026 |
| Organization | University of Reading |
| Journal Name | Nutrition Research |
| Authors | Constance Gayet-Boyer, Fanny Tenenhaus-Aziza, Moises Torres-Gonzalez, D. Ian Givens, Cindy Schweitzer |
| Population | Thousands of people in Europe, Canada, and the United States |
| Sample Size | 22 studies |
| Methods | Systematic Review |
| Outcome | Risk of heart disease, stroke, cardiovascular death, type 2 diabetes |
| Results | Dairy trans fats not linked to higher cardiovascular risk. |
Literature Review: Related Studies
To situate these findings within the broader evidence base, we searched the Consensus database of over 200 million research papers using the following queries:
- dairy trans fats cardiovascular health
- industrial vs natural trans fats effects
- natural fats heart disease risk comparison
Below, we organize the key findings from related studies into major thematic questions:
| Topic | Key Findings |
|---|---|
| Do all trans fats carry the same cardiovascular risk? | - Industrial trans fats consistently increase cardiovascular risk, whereas ruminant (dairy) trans fats do not show the same association in population studies 2 5 11 14. - Both types can affect blood cholesterol, but industrial sources have a stronger negative impact on HDL/LDL ratios and inflammation 3 7 8. |
| What are the biological mechanisms differentiating industrial and dairy trans fats? | - Industrial trans fats promote inflammation, endoplasmic reticulum stress, and adverse lipid changes; ruminant trans fats may have neutral or less harmful effects in animal and cell studies 3 9. - Some ruminant-derived trans fats, such as conjugated linoleic acid (CLA), may have beneficial or neutral effects 8 9. |
| How do long-term population studies assess dairy trans fats and disease risk? | - Higher biomarkers of dairy fat (including trans fatty acids) are not associated with increased cardiovascular events or mortality in cohort studies 5 11. - Some studies even suggest a possible inverse association between certain ruminant trans fatty acids and type 2 diabetes 11. |
| Are there any risks associated with natural trans fats in specific populations or contexts? | - Some controlled trials indicate modest effects on cholesterol markers, especially at high intakes or in women, but these do not translate into clear clinical risk in long-term studies 6 7 8. - Total dietary trans fat intake, when high, remains a concern regardless of source, though typical dairy intakes are much lower 4 14. |
Do all trans fats carry the same cardiovascular risk?
Related research strongly supports the distinction between industrial and dairy trans fats. Industrial trans fats, found in partially hydrogenated oils, are consistently linked to increased risks of heart disease and cardiovascular mortality in both epidemiological and clinical studies, while ruminant-derived trans fats from dairy do not show this association in long-term observational data. The new study reinforces and expands on this consensus by systematically reviewing both controlled trials and population studies, finding no increased risk from dairy trans fats.
- Industrial trans fats increase LDL cholesterol and lower HDL cholesterol, while dairy trans fats have a much weaker or absent effect on these markers 2 7 8.
- Meta-analyses and systematic reviews report that only industrial trans fats (not ruminant/dairy trans fats) are associated with increased coronary heart disease and mortality 5 11 14.
- The American Heart Association and other major guidelines have focused their warnings and regulations on industrial trans fats, not those from dairy 13.
- The present review adds further weight by including recent population data and controlled feeding studies, finding no evidence of harm from naturally occurring dairy trans fats 5 11.
What are the biological mechanisms differentiating industrial and dairy trans fats?
Mechanistic and intervention studies provide insight into why industrial and natural trans fats might have different health impacts. Industrial trans fats promote inflammation, endoplasmic reticulum stress, and negative changes in cholesterol metabolism, while dairy trans fats—particularly certain isomers like conjugated linoleic acid—may be metabolized differently and have neutral or even beneficial effects in some contexts. The new review’s findings are consistent with these mechanistic differences.
- Industrial trans fats (e.g., elaidic acid) stimulate inflammatory pathways and disrupt normal lipid metabolism 3.
- Ruminant trans fats such as vaccenic acid and c9,t11-CLA have shown neutral or beneficial effects in preclinical studies, although human data are less definitive 8 9.
- Some randomized controlled trials found both industrial and ruminant trans fats can raise LDL cholesterol, but industrial trans fats have a greater impact on lowering HDL cholesterol 7 8.
- The new study’s finding that dairy trans fats do not raise cardiovascular risk aligns with mechanistic evidence that these fats may not trigger the same pathogenic processes as industrial trans fats 3 9.
How do long-term population studies assess dairy trans fats and disease risk?
Multiple cohort studies and meta-analyses report that higher intakes or blood levels of dairy-derived trans fats are not associated with an increased risk of heart disease, stroke, or cardiovascular death. Some studies have even found inverse relationships with type 2 diabetes for certain ruminant trans fatty acids. The new review adds further evidence by synthesizing both biomarker and dietary intake data from large populations.
- Cohort studies using objective biomarkers of dairy fat intake show no association with increased cardiovascular risk and, in some cases, a reduced risk of heart failure 5.
- Meta-analyses confirm that ruminant trans fats do not increase the risk of cardiovascular disease or death, in contrast to industrial trans fats 11 14.
- Some population studies suggest an inverse association between ruminant trans-palmitoleic acid and type 2 diabetes 11.
- The new study’s comprehensive review of cohort data supports these findings, suggesting that concerns over dairy trans fats may be unwarranted at typical intake levels 5 11.
Are there any risks associated with natural trans fats in specific populations or contexts?
Some controlled feeding trials have detected modest increases in LDL cholesterol from high intakes of ruminant trans fats, particularly in women, though these changes have not been linked to higher clinical risk in long-term studies. Overall, typical dietary exposures to dairy trans fats are much lower than levels that might cause concern, but total trans fat intake—especially from processed foods—remains an important consideration.
- Controlled trials indicate that, at high intakes, both industrial and ruminant trans fats can affect lipid profiles, but effects are generally more pronounced with industrial sources 6 7 8.
- Some studies suggest isomer- and sex-specific effects, with LDL cholesterol increases observed in women consuming high ruminant trans fat diets 6.
- Epidemiological data do not show increased risk at typical dietary intakes of dairy trans fats 5 11.
- The new review emphasizes that natural dairy trans fats are consumed in much smaller amounts than industrial trans fats historically were, and that current population exposures are not associated with adverse outcomes 4 14.
Future Research Questions
Although this comprehensive review strengthens the evidence that naturally occurring dairy trans fats are not associated with increased cardiovascular risk, questions remain regarding their long-term effects, potential impacts in specific subgroups, and underlying biological mechanisms. Further research is needed to clarify these areas and to inform dietary guidelines as food systems and consumption patterns continue to evolve.
| Research Question | Relevance |
|---|---|
| What are the long-term health effects of high intake of dairy trans fats? | Most people consume small amounts of dairy trans fats, but the effects of consistently high intakes over decades are less well understood, especially in diverse populations 5 6. |
| Do genetic or sex differences modify the body’s response to natural trans fats? | Some studies indicate sex-specific effects on lipid profiles, but the role of genetic variation in trans fat metabolism and disease risk remains unclear 6 7. |
| What are the molecular mechanisms underlying the different effects of industrial and dairy trans fats? | Mechanistic studies suggest industrial and ruminant trans fats act differently in the body, but more research is needed to clarify these pathways and their clinical relevance 3 9. |
| Are there specific subpopulations (e.g., those with metabolic syndrome) that are more sensitive to dairy trans fats? | Most studies focus on healthy adults; understanding effects in individuals with pre-existing metabolic or cardiovascular conditions could guide personalized dietary advice 4 11. |
| How do different types of dairy processing affect the composition and health impact of natural trans fats? | The impact of modern dairy processing and animal feeding practices on trans fat composition and subsequent health effects is not fully understood and may influence risk profiles 1 2. |